Annual Revenue
$24.09 M
+$19.75 M+454.42%
December 31, 2023
Summary
- As of February 20, 2025, SBFMW annual revenue is $24.09 million, with the most recent change of +$19.75 million (+454.42%) on December 31, 2023.
- During the last 3 years, SBFMW annual revenue has risen by +$24.02 million (+33638.67%).
- SBFMW annual revenue is now at all-time high.
Performance
SBFMW Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$8.44 M
-$867.89 K-9.33%
September 30, 2024
Summary
- As of February 20, 2025, SBFMW quarterly revenue is $8.44 million, with the most recent change of -$867.89 thousand (-9.33%) on September 30, 2024.
- Over the past year, SBFMW quarterly revenue has stayed the same.
- SBFMW quarterly revenue is now -9.33% below its all-time high of $9.30 million, reached on June 30, 2024.
Performance
SBFMW Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$32.96 M
+$2.48 M+8.13%
September 30, 2024
Summary
- As of February 20, 2025, SBFMW TTM revenue is $32.96 million, with the most recent change of +$2.48 million (+8.13%) on September 30, 2024.
- Over the past year, SBFMW TTM revenue has stayed the same.
- SBFMW TTM revenue is now at all-time high.
Performance
SBFMW TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
SBFMW Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +454.4% | 0.0% | 0.0% |
| 3 y3 years | +10000.0% | +6777.7% | +10000.0% |
| 5 y5 years | +5287.5% | +10000.0% | +10000.0% |
SBFMW Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | >+9999.0% | -9.3% | +9810.0% | at high | >+9999.0% |
| 5 y | 5-year | at high | >+9999.0% | -9.3% | >+9999.0% | at high | >+9999.0% |
| alltime | all time | at high | -100.0% | -9.3% | -100.0% | at high | -100.0% |
Sunshine Biopharma Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $8.44 M(-9.3%) | $32.96 M(+8.1%) |
| Jun 2024 | - | $9.30 M(+23.4%) | $30.48 M(+14.0%) |
| Mar 2024 | - | $7.54 M(-1.8%) | $26.74 M(+11.0%) |
| Dec 2023 | $24.09 M(+454.4%) | $7.68 M(+28.9%) | $24.09 M(+18.4%) |
| Sep 2023 | - | $5.96 M(+7.1%) | $20.35 M(+40.1%) |
| Jun 2023 | - | $5.56 M(+13.6%) | $14.53 M(+59.3%) |
| Mar 2023 | - | $4.89 M(+24.2%) | $9.12 M(+109.8%) |
| Dec 2022 | $4.35 M(+1802.4%) | $3.94 M(+2866.6%) | $4.35 M(+785.3%) |
| Sep 2022 | - | $132.81 K(-11.6%) | $490.88 K(+20.2%) |
| Jun 2022 | - | $150.31 K(+22.6%) | $408.45 K(+31.3%) |
| Mar 2022 | - | $122.64 K(+44.1%) | $311.01 K(+36.2%) |
| Dec 2021 | $228.43 K(+219.9%) | $85.12 K(+69.0%) | $228.43 K(+33.3%) |
| Sep 2021 | - | $50.38 K(-4.7%) | $171.32 K(+24.1%) |
| Jun 2021 | - | $52.87 K(+32.0%) | $138.09 K(+37.6%) |
| Mar 2021 | - | $40.06 K(+43.0%) | $100.37 K(+40.5%) |
| Dec 2020 | $71.41 K(+238.1%) | $28.01 K(+63.3%) | $71.41 K(+32.4%) |
| Sep 2020 | - | $17.15 K(+13.2%) | $53.95 K(+22.3%) |
| Jun 2020 | - | $15.14 K(+36.4%) | $44.13 K(+37.8%) |
| Mar 2020 | - | $11.10 K(+5.2%) | $32.02 K(-77.2%) |
| Dec 2019 | $21.12 K(-95.3%) | $10.56 K(+44.1%) | $140.64 K(-41.9%) |
| Sep 2019 | - | $7326.00(+141.5%) | $241.93 K(-34.9%) |
| Jun 2019 | - | $3033.00(-97.5%) | $371.54 K(-21.9%) |
| Mar 2019 | - | $119.73 K(+7.1%) | $475.76 K(+6.4%) |
| Dec 2018 | $447.20 K(>+9900.0%) | $111.84 K(-18.3%) | $447.20 K(+33.4%) |
| Sep 2018 | - | $136.94 K(+27.7%) | $335.36 K(+69.0%) |
| Jun 2018 | - | $107.25 K(+17.6%) | $198.42 K(+117.6%) |
| Mar 2018 | - | $91.17 K(>+9900.0%) | $91.17 K(>+9900.0%) |
| Dec 2017 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2016 | $0.00 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2016 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | - | $0.00(0.0%) | $1708.00(0.0%) |
| Dec 2015 | $1708.00(>+9900.0%) | $0.00(0.0%) | $1708.00(0.0%) |
| Sep 2015 | - | $0.00(-100.0%) | $1708.00(0.0%) |
| Jun 2015 | - | $1708.00(>+9900.0%) | $1708.00(>+9900.0%) |
| Mar 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2013 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2012 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2011 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2010 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Oct 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jul 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Apr 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jan 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Oct 2008 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jul 2008 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Apr 2008 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jan 2008 | - | $0.00(0.0%) | $0.00(0.0%) |
| Oct 2007 | - | $0.00 | $0.00 |
| Jul 2007 | $0.00 | - | - |
FAQ
- What is Sunshine Biopharma annual revenue?
- What is the all time high annual revenue for Sunshine Biopharma?
- What is Sunshine Biopharma annual revenue year-on-year change?
- What is Sunshine Biopharma quarterly revenue?
- What is the all time high quarterly revenue for Sunshine Biopharma?
- What is Sunshine Biopharma quarterly revenue year-on-year change?
- What is Sunshine Biopharma TTM revenue?
- What is the all time high TTM revenue for Sunshine Biopharma?
- What is Sunshine Biopharma TTM revenue year-on-year change?
What is Sunshine Biopharma annual revenue?
The current annual revenue of SBFMW is $24.09 M
What is the all time high annual revenue for Sunshine Biopharma?
Sunshine Biopharma all-time high annual revenue is $24.09 M
What is Sunshine Biopharma annual revenue year-on-year change?
Over the past year, SBFMW annual revenue has changed by +$19.75 M (+454.42%)
What is Sunshine Biopharma quarterly revenue?
The current quarterly revenue of SBFMW is $8.44 M
What is the all time high quarterly revenue for Sunshine Biopharma?
Sunshine Biopharma all-time high quarterly revenue is $9.30 M
What is Sunshine Biopharma quarterly revenue year-on-year change?
Over the past year, SBFMW quarterly revenue has changed by $0.00 (0.00%)
What is Sunshine Biopharma TTM revenue?
The current TTM revenue of SBFMW is $32.96 M
What is the all time high TTM revenue for Sunshine Biopharma?
Sunshine Biopharma all-time high TTM revenue is $32.96 M
What is Sunshine Biopharma TTM revenue year-on-year change?
Over the past year, SBFMW TTM revenue has changed by $0.00 (0.00%)